Boehringer Ingelheim GmbH is one of many pharma companies experimenting with new ways to leverage artificial intelligence (AI) to innovate their ways of distributing information and communicating with patients.
A frontrunner among such firms looking to adopt AI, augmented reality and new digital media tools, it has already identified...
Welcome to Scrip
Create an account to read this article
Already a subscriber?